NTAL Human

Non-T-cell Activation Linker Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Structure and Expression

NTAL is a single-pass type III membrane protein with key structural features:

  • Tyrosine-based motifs: Contains multiple YxxN motifs critical for phosphorylation-dependent signaling .

  • Lipid raft localization: Anchored to membrane microdomains that facilitate signal transduction .

  • Cellular distribution: Expressed in B cells, natural killer (NK) cells, mast cells, monocytes, and plasma cells .

Signaling Mechanisms

NTAL mediates signaling cascades through interactions with:

  • Grb2 (Growth factor receptor-bound protein 2): Binds phosphorylated NTAL to activate MAPK pathways .

  • Sos1 (Son of Sevenless 1): Facilitates Ras activation downstream of NTAL phosphorylation .

  • c-Cbl: Modulates ubiquitination and receptor internalization .

In mast cells, NTAL regulates high-affinity IgE receptor (FcεRI) signaling, influencing allergic responses . Unlike LAT, NTAL exhibits partial functional redundancy but cannot fully compensate for LAT deficiency in T cells .

Research Findings

  • Leukemia relevance: NTAL expression correlates with treatment outcomes in B-cell malignancies. Knockdown experiments show reduced proliferation in leukemic cell lines .

  • Cross-species conservation: Functional homologs exist in mice and rats, though human NTAL has distinct regulatory roles .

  • Phosphorylation dynamics: NTAL’s activation is tightly regulated by kinases (e.g., Syk, Lyn) and phosphatases, affecting signal duration and intensity .

Clinical and Therapeutic Implications

While direct therapeutic targeting of NTAL remains exploratory, its role in immune regulation highlights potential applications:

  • Autoimmunity: Modulating NTAL signaling could dampen pathological immune activation.

  • Oncology: NTAL inhibitors might sensitize resistant leukemia subtypes to chemotherapy .

Product Specs

Introduction
NTAL is an adaptor protein involved in signal transduction pathways initiated by various immune receptors. It plays a crucial role in FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells, contributing to allergic responses. Additionally, NTAL participates in BCR (B-cell antigen receptor)-mediated signaling in B cells, essential for antibody production, and FCGR1 (high affinity immunoglobulin gamma Fc receptor I)-mediated signaling in myeloid cells, involved in immune complex clearance. NTAL functions by linking the activation of these receptors and their associated kinases to downstream intracellular events through the recruitment of GRB2.
Description
Recombinant human NTAL protein, expressed in E. coli, is a single, non-glycosylated polypeptide chain comprising 238 amino acids (residues 27-243). The protein has a molecular weight of 26.2 kDa and includes a 21 amino acid His-tag fused at the N-terminus to facilitate purification by standard chromatography techniques.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
The provided solution of recombinant human NTAL is supplied in a buffer consisting of 20mM Tris-HCl at pH 8.0 and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the NTAL solution can be stored at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. To further enhance stability during long-term storage, consider adding a carrier protein such as 0.1% HSA or BSA. Repeated freeze-thaw cycles should be avoided to maintain protein integrity.
Purity
The purity of the recombinant human NTAL protein is greater than 80%, as determined by SDS-PAGE analysis.
Synonyms
LAT2, Linker for Activation of T CellsFamily Member 2, HSPC046, LAB, WBSCR15, WBSCR5, WSCR5, Non-T-cell activation linker, Linker for activation of B-cells, Membrane-associated adapter molecule, Williams-Beuren syndrome chromosomal region 5 protein, Williams-Beuren syndrome chromosomal region 15 protein.
Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MRCSRPGAKR SEKIYQQRSL REDQQSFTGS RTYSLVGQAW PGPLADMAPT RKDKLLQFYP SLEDPASSRY QNFSKGSRHG SEEAYIDPIA MEYYNWGRFS KPPEDDDANS YENVLICKQK TTETGAQQEG IGGLCRGDLS LSLALKTGPT SGLCPSASPE EDEESEDYQN SASIHQWRES RKVMGQLQRE ASPGPVGSPD EEDGEPDYVN GEVAATEA.

Q&A

What are the core ethical principles guiding human subject research?

Human subject research is guided by three fundamental ethical principles: respect for persons, beneficence, and justice. These principles inform all aspects of research design and implementation. Respect for persons acknowledges the autonomy of individuals and protects those with diminished autonomy, manifesting primarily through informed consent procedures. Beneficence requires researchers to maximize potential benefits while minimizing possible harms, which necessitates thorough risk assessment. Justice demands fair selection of research participants and equitable distribution of research benefits and burdens across populations .

Implementation methodology requires researchers to embed these principles throughout the research process by:

  • Developing comprehensive informed consent documents that clearly articulate risks, benefits, and alternatives

  • Establishing independent ethics committee oversight

  • Creating ongoing participant welfare monitoring mechanisms

  • Designing fair inclusion/exclusion criteria based on scientific necessity rather than convenience

These principles should not be viewed as mere procedural requirements but as substantive ethical foundations that shape the entire research enterprise.

How do international and regional frameworks protect human research subjects?

International and regional human rights frameworks create a comprehensive protection system for research participants. These frameworks establish both negative obligations (preventing harm) and positive obligations (ensuring rights protection) for states regarding human experimentation .

Methodologically, researchers must implement a multi-tiered compliance approach:

  • Identify all applicable international conventions relevant to the research context

  • Determine specific regional human rights instruments with jurisdiction

  • Incorporate national legislation and institutional requirements

  • Establish harmonized protocols that satisfy the highest standard across all applicable frameworks

  • Document compliance measures throughout the research process

This layered approach ensures that research meets not only minimum standards but embraces the highest level of human rights protection available across different juridical systems. When conflicts between frameworks arise, researchers should default to the most protective standards rather than seeking minimum compliance .

What constitutes valid informed consent in human subject research?

Valid informed consent represents the practical application of respect for persons and requires significantly more than obtaining a signature. Methodologically, researchers must ensure that consent is free, informed, and given prior to experimentation. This requires providing information that is:

  • Objectively accurate regarding research nature, consequences, and risks

  • Clear and accessible, accounting for participants' educational background and familiarity with scientific concepts

  • Presented in absence of pressure or coercion

  • Delivered in language appropriate to participants' comprehension level

The consent process should be conceptualized as an ongoing dialogue rather than a one-time event. Researchers should:

  • Provide information in multiple formats (written, verbal, visual)

  • Assess comprehension through interactive discussion

  • Create opportunities for questions throughout the research

  • Establish mechanisms for withdrawal without consequence

  • Regularly reaffirm consent, especially during longitudinal studies

This approach recognizes consent as a fundamental right rather than merely a procedural requirement, reflecting the human dignity and autonomy of research participants .

What are the essential components of effective experimental design for human behavior studies?

Effective experimental design for human behavior studies requires systematic planning across multiple dimensions. The methodological approach should include:

  • Research question formulation: Develop specific, testable hypotheses addressing well-defined aspects of human cognition or behavior

  • Variable identification: Clearly distinguish independent variables (manipulated conditions) from dependent variables (measured outcomes)

  • Control implementation: Establish appropriate controls to isolate causal relationships

  • Randomization protocols: Apply randomization to both participant assignment and stimulus presentation to minimize bias

  • Statistical power planning: Calculate required sample sizes based on expected effect sizes

  • Confound elimination: Identify and control for potential confounding variables

Researchers must particularly attend to the random distribution of subjects to experimental conditions, ensuring all participants have equal probability of assignment to any group. This prevents selection bias and strengthens causal inferences. Before full implementation, conducting pilot testing with a small sample enables identification of procedural issues, stimulus optimization opportunities, and unexpected confounds .

How should researchers appropriately assign subjects to experimental groups?

  • True randomization protocols using computational random number generation rather than arbitrary assignment

  • Stratified randomization when population characteristics might influence outcomes

  • Balanced assignment ensuring equal numbers across conditions when possible

  • Blinding procedures where neither participants nor researchers know group assignments

  • Documentation of assignment procedures for transparency and replication

The assignment methodology must eliminate any systematic bias that could predispose specific participants to particular experimental conditions. Researchers should verify and report the equivalence of groups on relevant demographic and baseline measures prior to intervention. For studies examining workplace stress, for example, randomization ensures that participants receiving different stimuli (e.g., 10 versus 100 emails hourly) are comparable on baseline stress measures, personality factors, and other relevant variables .

What methodological approaches can address the challenges of laboratory versus field experiments?

Laboratory and field experiments present distinct methodological challenges requiring different approaches:

Laboratory experiments provide controlled environments ideal for isolating causal mechanisms but may lack ecological validity. Methodologically, researchers should:

  • Standardize all environmental variables (lighting, sound, temperature)

  • Create detailed protocols for researcher-participant interactions

  • Implement precise timing mechanisms for stimulus presentation

  • Use standardized measurement tools with established psychometric properties

  • Consider how laboratory conditions might alter natural behaviors

Field experiments offer greater ecological validity but introduce potential confounds. Researchers should:

  • Identify and measure potential environmental influences

  • Develop unobtrusive observation methods

  • Create consistent testing conditions despite variable environments

  • Implement more robust statistical approaches to account for environmental noise

  • Document contextual factors that might influence results

A hybrid approach combining controlled laboratory assessments with field validation can maximize both internal and external validity. This methodological integration allows researchers to establish causal relationships under controlled conditions while confirming their relevance to real-world contexts .

What methodological approaches ensure fair selection of research participants?

Fair participant selection requires systematic attention to both scientific validity and justice principles. Methodologically, researchers should:

  • Develop inclusion/exclusion criteria based solely on scientific necessity

  • Implement recruitment strategies reaching diverse populations

  • Establish accessibility measures enabling participation across socioeconomic conditions

  • Apply consistent screening procedures to all potential participants

  • Document justifications for any population restrictions

The selection methodology must recognize and address the unequal power dynamic between researchers and participants, particularly when structural inequalities exist. Differential treatment of participant populations requires objective and reasonable justification. For example, selecting groups based on exposure to specific disease vectors represents scientifically justified selection, while restricting research to vulnerable populations without rational connection to research questions violates non-discrimination principles .

When developing selection criteria, researchers should:

  • Articulate scientific rationales for all criteria

  • Ensure criteria do not unnecessarily exclude underrepresented groups

  • Consider how selection decisions might reinforce or challenge existing inequities

  • Establish mechanisms for periodic review of participation demographics

This rights-based approach to participant selection clarifies entitlements and duties while facilitating accountability processes that protect vulnerable populations .

How can researchers protect vulnerable populations while ensuring their appropriate inclusion in research?

Protection of vulnerable populations requires specialized methodological approaches that balance inclusion with safeguards. Researchers should:

  • Develop enhanced consent procedures appropriate to specific vulnerabilities

  • Implement additional oversight mechanisms beyond standard IRB approval

  • Create participant advocates independent from the research team

  • Establish ongoing monitoring of participant welfare

  • Design compensation structures that avoid undue inducement

Methodologically, researchers must recognize how structural inequalities may exacerbate power imbalances and impair informed consent. This requires careful scrutiny to ensure vulnerable populations are not selected merely because manipulation is easier. When working with vulnerable groups, researchers should:

  • Engage community representatives in research design and oversight

  • Develop capacity-building components benefiting participant communities

  • Implement additional confidentiality protections

  • Create accessible grievance mechanisms

  • Ensure findings benefit the studied population

A human rights framework provides clear normative foundations for claims and facilitates accountability processes that protect vulnerable groups while ensuring research benefits extend to these populations. This approach recognizes that exclusion from research can perpetuate inequities in scientific knowledge and healthcare advances .

What advanced approaches can address selection bias in human subject research?

Advanced methodological approaches to selection bias require sophisticated statistical and design techniques. Researchers should implement:

  • Propensity score matching to balance confounding variables across comparison groups

  • Multiple imputation techniques for handling missing data that might create selection artifacts

  • Inverse probability weighting to adjust for selection probabilities

  • Sensitivity analyses quantifying potential impact of unmeasured selection factors

  • Directed acyclic graphs (DAGs) to visualize and address selection bias pathways

When selection is influenced by factors related to research outcomes, researchers must:

  • Model the selection process explicitly rather than assuming randomness

  • Document all stages of participant flow from recruitment through analysis

  • Compare participants to non-participants on observable characteristics

  • Consider instrumental variable approaches when selection seems endogenous

  • Apply Heckman correction procedures when appropriate

What methodological considerations apply to developmental neurotoxicity (DNT) research involving human subjects?

Developmental neurotoxicity research involving humans requires specialized methodological approaches addressing both scientific validity and ethical protection. Researchers should implement:

  • Longitudinal study designs capturing delayed consequences of early life exposures

  • Multi-modal assessment combining behavioral, cognitive, physiological, and neuroimaging measures

  • Careful identification and control of confounding factors (genetic variability, complex exposures, lifestyle factors)

  • Comprehensive statistical models accounting for developmental trajectories

  • Integration of mechanistic insights from complementary in vitro systems

Methodologically, researchers must distinguish between direct-acting compounds affecting neural development and indirect toxicants acting through systems like thyroid function. This requires:

  • Careful selection of reference compounds with established mechanisms

  • Validated biomarkers connecting exposure to developmental outcomes

  • Consideration of critical developmental windows

  • Attention to dose-response relationships

  • Integration of fundamental neurodevelopmental processes (precursor cell proliferation, neuronal and glial differentiation, synaptogenesis, myelination)

Human DNT research faces particular challenges due to the time lag between exposure and measurable outcomes. Researchers should develop comprehensive approaches integrating epidemiological findings with mechanistic insights, acknowledging that complex endpoints like neuropsychological performance reflect multiple interacting developmental processes. This integration strengthens both scientific validity and translational relevance .

How should researchers address data contradictions between in vitro and in vivo human studies?

Resolving contradictions between in vitro and in vivo findings requires systematic methodological approaches that contextualize and integrate divergent results. Researchers should:

  • Develop adverse outcome pathway (AOP) models connecting molecular initiating events to adverse outcomes

  • Map specific endpoints across systems to identify where divergence occurs

  • Consider toxicokinetic factors present in vivo but absent in vitro

  • Evaluate the biological coverage of in vitro systems regarding fundamental processes

  • Implement weight-of-evidence approaches integrating multiple data streams

When contradictions emerge, researchers should methodically:

  • Assess the biological relevance of each system to the specific question

  • Consider exposure regimens and whether they appropriately model human scenarios

  • Evaluate metabolic competence differences between systems

  • Examine whether endpoints measure equivalent biological processes

  • Consider whether contradictions represent true disagreement or complementary insights

This integrative approach recognizes that in vitro systems may capture direct effects on fundamental biological processes while missing system-level compensatory mechanisms or indirect effects. Conversely, in vivo findings may capture complex outcomes without revealing specific mechanisms. By systematically addressing these complementary perspectives, researchers can develop more comprehensive understanding of toxicological relationships .

What advanced methods exist for studying human cognition and behavior in virtual versus physical environments?

Comparative research on human cognition and behavior across virtual and physical environments requires sophisticated methodological approaches addressing the unique characteristics of each context. Researchers should implement:

  • Matched experimental paradigms with equivalent cognitive/behavioral demands

  • Cross-over designs where participants experience both environments

  • Multi-level measurement capturing behavioral, physiological, and subjective responses

  • Presence assessment quantifying the psychological experience of virtual environments

  • Systematic evaluation of transfer effects between virtual and physical contexts

Methodologically, researchers must address specific challenges including:

  • Controlling sensory fidelity across environments

  • Matching interaction affordances and constraints

  • Accounting for learning effects and habituation

  • Developing equivalent social presence in collaborative tasks

  • Creating comparable measurement approaches across contexts

Advanced approaches might incorporate mobile physiological monitoring (heart rate, galvanic skin response, eye tracking) synchronized with behavioral measures to assess how environmental differences affect information processing, attention allocation, and stress responses. Neuroimaging techniques can provide insights into potential differences in neural activation patterns across environments, while standardized presence questionnaires quantify subjective experience differences .

This research area represents a methodological frontier requiring innovative approaches to isolate environmental effects from technology-related artifacts, with significant implications for training, rehabilitation, and educational applications.

What methodologies ensure quality control during human subject data collection?

Quality control during human subject data collection requires comprehensive methodological approaches addressing potential sources of error and bias. Researchers should implement:

  • Standardized operating procedures (SOPs) documenting all data collection processes

  • Rigorous training protocols with competency verification for all research personnel

  • Regular calibration of all measurement instruments with documentation

  • Real-time data validation checks identifying outliers and inconsistencies

  • Systematic quality assurance monitoring with independent verification

Before full implementation, pilot testing serves as a critical quality control mechanism, allowing researchers to:

  • Identify and resolve procedural inconsistencies

  • Optimize stimulus parameters and timing

  • Test equipment functionality under experimental conditions

  • Evaluate participant comprehension of instructions

  • Estimate time requirements and participant burden

During active data collection, researchers should:

  • Monitor protocol adherence through observation or recording

  • Implement double-data entry or automated verification for critical variables

  • Document any protocol deviations with justification

  • Conduct periodic inter-rater reliability assessments

  • Maintain comprehensive audit trails for all data modifications

These methodological approaches recognize that data quality determines research validity, particularly in human studies where variability and contextual factors introduce complexity. By implementing systematic quality control throughout data collection, researchers strengthen both internal validity and replicability .

How can researchers effectively address the paradox of replication and innovation in human subject research?

Balancing replication and innovation presents a methodological challenge requiring systematic approaches. Researchers should implement:

  • Registered reports specifying hypotheses and methods before data collection

  • Multi-lab collaborative studies testing replicability across contexts

  • Systematic variation frameworks identifying boundary conditions

  • Integration of direct replication with conceptual extension

  • Open science practices facilitating cumulative knowledge building

Methodologically, researchers can address this paradox by:

  • Beginning with direct replication establishing robustness of key findings

  • Systematically varying theoretical moderators to test generalizability

  • Implementing sequential innovation building on established findings

  • Developing prediction markets assessing replication likelihood

  • Creating comprehensive research programs rather than isolated studies

This approach recognizes that meaningful innovation requires solid foundations in replicable findings, while replication without theoretical advancement limits scientific progress. By conceptualizing replication and innovation as complementary rather than competing goals, researchers can develop progressive research programs that both validate established knowledge and extend theoretical boundaries .

What advanced methodological considerations apply to research during public health emergencies?

Public health emergencies create unique research contexts requiring specialized methodological approaches balancing urgency with rigor and protection. Researchers should implement:

  • Adaptive trial designs allowing protocol modifications as knowledge evolves

  • Staged consent processes addressing evolving risk-benefit profiles

  • Independent data monitoring committees with expedited review procedures

  • Shared control group designs maximizing statistical power while minimizing participant exposure

  • Pre-approved protocol templates expediting implementation while maintaining standards

During emergencies, researchers must carefully consider:

  • Whether proposed derogations from normal procedures are justified by necessity

  • How urgency affects power dynamics and voluntary participation

  • Whether vulnerable populations face disproportionate research burdens

  • How to maintain scientific validity despite expedited timelines

  • How to integrate research with therapeutic interventions when appropriate

These considerations recognize that while public health emergencies may justify modified procedures, core ethical principles remain non-derogable. The methodological approach must balance the urgent need for knowledge with protection of participant rights and scientific integrity. By developing emergency research frameworks proactively, research communities can respond rapidly while maintaining appropriate protections .

Product Science Overview

Introduction

Non-T-cell Activation Linker (NTAL), also known as Linker for Activation of B cells (LAB), is a transmembrane adaptor protein. It is structurally and evolutionarily related to the Linker for Activation of T cells (LAT). NTAL is expressed in various immune cells, including B cells, natural killer (NK) cells, mast cells, and macrophages .

Structure and Expression

NTAL is a 30 kDa double-palmitoylated protein. It is rapidly phosphorylated after the engagement of B cell receptors (BCR) or Fc receptors (FcR) . The protein is encoded by the WBSCR5 gene, which is located in the Williams-Beuren syndrome chromosomal region . The amino acid sequence of NTAL includes several tyrosine residues that become phosphorylated upon activation, facilitating the recruitment of downstream signaling molecules .

Function

NTAL plays a crucial role in the negative regulation of early stages of BCR-dependent B cell signaling. It serves as a negative regulator in mast cells as well, although it also contributes to some activation processes in these cells, partially overlapping with LAT function . In T cells, NTAL negatively regulates T cell receptor (TCR) signaling, which is essential to avoid uncontrolled immune responses .

Research and Applications

Recent studies have shown that NTAL expression in Jurkat cells, a model for T cells, decreases calcium fluxes and PLC-γ1 activation upon stimulation through the TCR complex . This suggests that NTAL has a potential role in autoimmune disorders, such as rheumatoid arthritis, by negatively regulating TCR signaling .

Recombinant NTAL proteins are used in various research applications, including blocking assays and control experiments . These proteins are typically expressed in systems like E. coli and purified for use in laboratory settings .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.